“…Among this class of compounds, spirochromanone is a well-recognized privileged structure that has been commonly found in a plenty of chemical compounds with diverse biological activities. These compounds exhibit significant biological activities such as anticancer (Atta et al, 2010;El-Desoky et al, 2013), antitubercular (Mujahid et al, 2013;Mujahid et al, 2015), antimicrobials (Feng et al, 2014), histamine-3 antagonists (Becknell et al, 2012), antiarrhythmic (Elliott et al, 1992), acetyl-CoA carboxylase (ACC) inhibitors (Shinde et al, 2009;Huang et al, 2015), stearoyl-CoA desaturase-1 (SCD)-1 inhibitors (Uto et al, 2010), histone deacetylase (HDAC) inhibitors (Varasi et al, 2011;Thaler et al, 2016), antimalarial (Roberts et al, 2016), growth hormone secretagogues (Yang et al, 1998) and δ opioid receptor agonists (Le Bourdonnec et al, 2008). Thaler et al have reported a series of spirochromanes and evaluated their activity against HDAC as a well-established anticancer target (Thaler et al, 2016).…”